期刊文献+

生物检材中佐匹克隆的GC/μECD测定 被引量:2

Determination of Zopiclone in Biological Matrices by GC/μECD
原文传递
导出
摘要 目的:建立液-液萃取、GC/μECD气相色谱测定生物检材中佐匹克隆的方法。方法:以家兔为模型动物,500 mg佐匹克隆标准品灌胃家兔,6.5小时后处死,取其胃、肝、血、脑、心脏、尿,采用乙醚液-液萃取提取,Rtx-5毛细管柱分离,电子捕获检测器检测,标准曲线法定量。结果:该方法灵敏度达0.02μg/mL,在0.05-50μg/mL范围内线性关系良好;低、中、高3种浓度的加样回收率分别为91.7%、99.5%、94.4%,相对标准偏差(RSD)均小于5%;佐匹克隆在家兔脏器中的浓度分别为7.31μg/mL(血液)、7.63μg/g(肝脏)、7.96μg/g(脑)、14.67μg/g(心脏)、32.18μg/g(胃组织)、42.65μg/mL(尿液),在各脏器中呈特异性分布。结论:该法操作简单、灵敏度高,结果可靠,完全满足临床检测及公安机关在办理佐匹克隆麻醉案件中的需要。 Objective: To develop a method for determination of zopiclone in biological matrices by liquid-liquid extraction and GC/μECD. Methods: The model animals-rabbits were sacrificed 6.5 hours after gastric perfusion of 500mg zopiclone. The biological matrices including stomach, liver, blood, brain, heart and urine were extracted by aether, separated by Rtx-5 columm and then detected by μECD detector. Results: The detection limit of this method was 0.02μg/mL.It had a good linear relationship with zopiclone in the range of 0.05-50 μg/mL.The mean recoveries of low, middle and high concentrations were 91.7 %, 99.5 %, 94.4 %, and all of the relative standard deviation (RSD) were less than 5 %.The concentrations of zopiclone in the tissues were 7.31 μg/mL (blood), 7.63μg/g(liver), 7.96 μg/g(brain), 14.67 μg/g(heart), 32.18 μg/g(stomaeh)and 42.65μg/mL(urine) respectively. This showed zopiclone was differentially distributed in the tissues. Conclusions: The method is easy to operate, sensitive and reliable, and could be applied to clinical determination and forensic.identification.
出处 《现代生物医学进展》 CAS 2013年第2期225-227,262,共4页 Progress in Modern Biomedicine
基金 公安部应用创新计划项目[2005YYCXHNST092]
关键词 佐匹克隆 生物检材 GC μECD Zopiclone Biological matrices GC/μECD
  • 相关文献

参考文献20

二级参考文献49

  • 1[1]Whitehead C,Sanders L,Apadurai I,et al.Zopiclone as a preoperative night hypnotic:a double-blind compar-ison with temazepam and placebo[J].Br J ]Anaesth,1994,72(4):443.
  • 2[2]Fernandez C,Martin C,Gimenez F,et al.Clinical pha-rmacokinetics of zopiclone[J].Clin Pharmacokinet,1995,29(6):431.
  • 3[3]Fernandez C,Gimenez F,Thuillier A,et al.Stereosele-ctive binding of zopiclone to human plasma proteins[J]. Chirality,1999,11(2):129.
  • 4[4]Becquemont L,Mouajjah S,Escaffre O,et al.Cytochr-ome P450 3A4 and 2C8 are involved in zopiclone metabo-lism[J].Drug Metab Dispos,1999,27(9):1 068.
  • 5[5]Hajak G.A comparative assessment of the risks and be-nefits of zopiclone:a review of 15 years clinical experience[J].Drug Saf,1999,21(6):457.
  • 6[6]Hemmeter U,Muller M,Bischof R,et al.Effect of zop-iclone and temazepam on sleep EEG parameters,psych-omotor and memory functions in healthy elderly volun-teers[J].Psychopharmacology(Berl),2000,147(4):384.
  • 7[7]Disayavanish C,Srisurapanont M,Disayavanish P.Zop-iclone in the treatment of insomina:an open clinical tr-ial[J].J Med Assoc Thai,1998,81(6):393.
  • 8[8]Lader M.Zopiclone:is there any dependence and abuse potential?[J].J Neurol,1997,244(4 Suppl 1):18.
  • 9[9]Noble S,Langtry HD,Lamb HM.Zopiclone:An update of its pharmacology,clinical efficacy and tolerability in the treatment of insomnia[J].Drugs,1998,55(2):277.
  • 10[10]Doble A.New insights into the mechanism of action of hypnotics[J].J Psychopharmacol,1999,13(4 Suppl 1):11.

共引文献71

同被引文献23

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部